You are here

  • Home
  • Archive
  • Volume 71, Issue 2
  • In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rezaei H, Saevarsdottir S, Forslind K, et al
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial
Annals of the Rheumatic Diseases 2012;71:186-191.